Questions About Cancer? 1-800-4-CANCER
NCI Cancer Center News

Gene that controls aggressiveness in breast cancer cells identified

  • Posted: July 5, 2013

In a discovery that sheds new light on the aggressiveness of certain breast cancers, Whitehead Institute and MIT researchers have identified a transcription factor, known as ZEB1, that is capable of converting non-aggressive basal-type cancer cells into highly malignant, tumor-forming cancer stem cells (CSCs). Intriguingly, luminal breast cancer cells, which are associated with a much better clinical prognosis, carry this gene in a state in which it seems to be permanently shut down. MIT is home to the David H. Koch Institute for Integrative Cancer Research.

Click here to read full press release.

###

Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.